Uploads by Raymond Pasiliao

Ipophl Memorandum Circular No. 2023-002 - Amendments to Ipophl Mc No. 16-012 in Relation to Tm-related Fees

IPOPHL Memorandum Circular No. 2022-016 Revised Implementing Rules and Regulations for Patents, Utility Models and Industrial Designs of 2022.PDF

AP_BOT_04-2018-000006_Decision

AP_BOT_04-2018-000013_Decision

AP_BOT_04-2018-000004_Decision

AP_BOT_04-2018-000005_Decision

AP_BOT_04-2018-000012_Decision

DO_s2021_021

DO_s2021_019

DO_s2021_020

DM_s2021_031

DM_s2021_030

Memorandum Circular No. 2020_006 Updated Advisory on IPOPHL Services in the Light of Covid-19 (1)

Memorandum Circular No. 2020_007 Supplemental Advisory Re_ Applications Whose Priority Date Falls From March 16, 2020 to April 14, 2020 (1)

Memorandum Circular No. 2020-008 Granting an Extension Period of Forty-Five (45) Calendar Days for Payments and Filing of Replies, Pleadings, Papers, Etc. With Due Dates From March 16, 2020 – April 14, 2020 (1)

Memorandum Circular No. 2020-010 Advisory on Deadline for the Filing of Written Third Party Observation (TPO) for Inventions and Adverse Information (AI) for Utility Models and Industrial Designs, For Personal Protective Equipment, Medical

Memorandum Circular No. 2020-009 Updated Advisory on IPOPHL Services in Light of the Extension of the Enhanced Community Quarantine to 30 April 2020

IPOPHL Memorandum Circular No. 2021- 008 Extension of Deadlines for Filing and Payments

IPOPHL Memorandum Circular No. 2021-010_Alternative Work Arrangment During the Modified Enhanced Community Quarantine

IPOPHL Memorandum Circular No. 2021-011_Extension of Deadlines For Filings and Payments

IPOPHL Memorandum Circular No. 2021- 007 Alternative Work Arrangement in the Light of the Extension of the Enhanced Comunity Quarantine

IPOPHL Memorandum Circular No. 2021- 005 Extension of Deadlines in Light of the Declaration of an Enhanced Community Quarantine

Bayanihan Heal As One Act

PCC Memorandum Circular No. 19-001

DTI Directory of Key Officials

FDA Advisory re sale of medicines on the internet

FDA Advisory No. 2015-007

FDA Order re Guidelines on Classification.pdf

WTO Exam.S1030310